Acute disseminated encephalomyelitis in a patient vaccinated against SARS-CoV-2
- PMID: 34480527
- PMCID: PMC8528462
- DOI: 10.1002/acn3.51447
Acute disseminated encephalomyelitis in a patient vaccinated against SARS-CoV-2
Abstract
Acute disseminated encephalomyelitis (ADEM) is a demyelinating disease, and there are some data that link this event with various vaccinations. We report a young female admitted to the hospital with headache, fever, back pain, nausea, vomiting, and urinary retention. Two weeks prior, she received the first dose of SARS-CoV-2 mRNA vaccine. Brain and spinal cord magnetic resonance imaging (MRI) showed distinctive for ADEM widespread demyelinating lesions. The patient was successfully treated with methylprednisolone.
© 2021 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.
Conflict of interest statement
All authors declare that there is no conflict of interest.
Figures
Comment in
-
Before attributing encephalomyelitis to SARS-CoV-2 vaccinations thoroughly exclude differentials.Ann Clin Transl Neurol. 2021 Nov;8(11):2222-2223. doi: 10.1002/acn3.51469. Epub 2021 Nov 15. Ann Clin Transl Neurol. 2021. PMID: 34783196 Free PMC article. No abstract available.
References
-
- Stratton K, Ford A, Rusch E, Clayton EW, eds. Institute of Medicine Adverse Effects of Vaccines: Evidence and Causality. National Academies Press; 2012. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources